NCT04607538 (FKC) is a clinical trial of No intervention is made in Patellar Dislocation, sponsored by Hvidovre University Hospital.

Who is sponsoring NCT04607538?

NCT04607538 is sponsored by Hvidovre University Hospital.

What drugs are being tested in NCT04607538?

Interventions in NCT04607538: No intervention is made.

What condition does NCT04607538 study?

NCT04607538 studies Patellar Dislocation, ACL Injury, Meniscus Lesion, Trochlear Dysplasia.

Is NCT04607538 still recruiting?

NCT04607538 is currently recruiting now. Last updated 17 February 2023.

Last reviewed 2023-02-17 · How we verify

NCT04607538: FKC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations.

Recruiting now Last updated 17 February 2023

What this trial tests

trial testing No intervention is made in Patellar Dislocation in 100 participants. Currently enrolling.

Timeline

1 March 2022

Primary endpoint
1 November 2024

1 December 2051

Quick facts

Lead sponsor	Hvidovre University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 March 2022
Primary completion	1 November 2024
Estimated completion	1 December 2051
Sites	1 location across Denmark

Drugs / interventions tested

No intervention is made

Conditions studied

Patellar Dislocation — all drugs for Patellar Dislocation →
ACL Injury — all drugs for ACL Injury →
Meniscus Lesion — all drugs for Meniscus Lesion →
Trochlear Dysplasia — all drugs for Trochlear Dysplasia →

Sponsor

Hvidovre University Hospital

Who can join

Adults 15 to 20, any sex, with Patellar Dislocation or ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators intend to establish a national cohort including all persons in the ages from 15-20 years old with patellar instability (PI) or a prior knee injury (ACL-ruptur or meniscus damage) . The cohort will be nicknamed "The Faroese Knee Cohort". The overall aim is to investigate two groups. 1. The patella instability group, in which we intend to investigate the following. * Prevalence of patellar dislocation and trochlear dysplasia in the Faroe Islands. * Risk factors for patellar dislocations- * Heredity of trochlear dysplasia. * If there is a specific gene responsible for the development of trochlear dysplasia. * The development of retropatellar artrhosis, its onset and its impact on quality of life and function, 2. Knee injury group (ACL-ruptur or meniscus injury) * The prevalence of ACL-rupture and/or meniscus injury in this specific group in the Faroe Islands. * The impact on quality of life and function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

High prevalence of patellar dislocation and trochlear dysplasia in a geographically and genetically isolated society: an observational national cohort study from the Faroese Knee Cohort.
Eysturoy NH, Husum HC, Mortensen ES, Blønd L, et al · · 2024 · cited 1× · PMID 38240376 · DOI 10.2340/17453674.2024.35229

Verify or expand the search:

Other recruiting trials for Patellar Dislocation

Currently open trials in the same condition.

NCT06086080 — Non-operative Treatment in First-time Patellar Dislocation · NA · recruiting
NCT04554212 — Blood Flow Restriction Training After Patellar INStability · NA · recruiting
NCT04294199 — Effect of Early Range of Motion Following First Time Patellar Dislocation · NA · active not recruiting
NCT05706363 — Comparison of Two Graft Choices in Mediale Patellofemoral Ligament Reconstruction (MPFL) · NA · active not recruiting
NCT03076008 — The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofem · active not recruiting

Other Hvidovre University Hospital trials

Trials by the same sponsor.

NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
NCT07054216 — Probiotic for Infants · NA · recruiting
NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04607538 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
Last refreshed: 17 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04607538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing